Abstract
Our objective was to identify the sites of interaction of cannabinoids with cardiovascular sympathetic regulation in the rat. Effects on sympathetic tone were first determined in anaesthetised animals following i.v. administration of the drugs. Central effects were evaluated in anaesthetised rats receiving microinjections of cannabinoids into brain stem nuclei. Peripheral effects were identified in pithed rats with electrically stimulated sympathetic outflow. In anaesthetised and artificially ventilated rats, i.v. injection of the cannabinoid agonists WIN55212-2 and CP55940 decreased mean arterial pressure, heart rate and the plasma noradrenaline concentration. These effects were antagonized by the CB(1) cannabinoid receptor antagonist SR141716A. The bradycardia was abolished by the muscarinic acetylcholine receptor antagonist methylatropine. The decreases in mean arterial pressure and heart rate caused by cannabinoids in ventilated rats were much less pronounced than in spontaneously breathing rats. Microinjection of WIN55212-2 into the nucleus tractus solitarii had no effect. Microinjected into the rostral ventrolateral medulla oblongata, WIN55212-2 lowered mean arterial pressure slightly without changing other parameters. In pithed rats, WIN55212-2 inhibited the increases in mean arterial pressure, heart rate and the plasma noradrenaline concentration evoked by electrical stimulation of the sympathetic outflow. Our results show that activation of CB(1) cannabinoid receptors induces sympathoinhibition and enhancement of cardiac vagal tone, leading to hypotension and bradycardia. Presynaptic inhibition of noradrenaline release from terminals of postganglionic sympathetic neurons is the major component of the sympathoinhibition, but an effect in the rostral ventrolateral medulla oblongata may also contribute. The cannabinoid-evoked cardiovascular depression depends strongly on the respiratory state of the animals.
MeSH Terms
Animals
Atropine Derivatives/administration & dosage,pharmacokinetics
Benzoxazines
Bradycardia/chemically induced,physiopathology
Cannabinoids/adverse effects,antagonists & inhibitors,pharmacokinetics
Cardiovascular System/drug effects,physiopathology
Cyclohexanols/administration & dosage,pharmacokinetics
Disease Models, Animal
Dose-Response Relationship, Drug
Hypotension/chemically induced,physiopathology
Male
Medulla Oblongata/drug effects
Microinjections
Morpholines/administration & dosage,pharmacokinetics
Naphthalenes/administration & dosage,pharmacokinetics
Norepinephrine/blood,metabolism
Piperidines/administration & dosage,pharmacokinetics
Pyrazoles/administration & dosage,pharmacokinetics
Rats
Rats, Wistar
Receptor, Cannabinoid, CB1/antagonists & inhibitors,drug effects
Rimonabant
Sympathetic Fibers, Postganglionic/drug effects,physiology
Sympathetic Nervous System/drug effects
Chemicals
Atropine Derivatives
Benzoxazines
Cannabinoids
Cyclohexanols
Morpholines
Naphthalenes
Piperidines
Pyrazoles
Receptor, Cannabinoid, CB1
(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone
methylatropine
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol
Rimonabant
Norepinephrine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Niederhoffer Nathalie
Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Albertstrasse 25, 79104 Freiburg i. Br., Germany.
[email protected]
Schmid Karin
Szabo Bela
References (35)
35 references, click to expand
-
The subretrofacial vasomotor nucleus: anatomical, chemical and pharmacological properties and role in cardiovascular regulation.
Prog Neurobiol. 1994 Feb;42(2):197-227
PMID: 8008825
-
Cardiovascular effects of endocannabinoids--the plot thickens.
Prostaglandins Other Lipid Mediat. 2000 Apr;61(1-2):71-84
PMID: 10785543
-
Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation.
Br J Pharmacol. 1999 Jan;126(2):457-66
PMID: 10077239
-
Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry.
Neuroscience. 1992;48(3):655-68
PMID: 1376455
-
Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.
J Pharmacol Exp Ther. 1997 Jun;281(3):1030-7
PMID: 9190833
-
Cardiovascular and respiratory effects of cannabis in cat and rat.
Br J Pharmacol. 1973 Sep;49(1):1-10
PMID: 4787563
-
Characterization of the absorption phase of marijuana smoking.
Clin Pharmacol Ther. 1992 Jul;52(1):31-41
PMID: 1320536
-
Respiratory and cardiovascular depressant effects of nabilone, N-methyllevonantradol and delta 9-tetrahydrocannabinol in anesthetized cats.
J Pharmacol Exp Ther. 1983 Nov;227(2):508-16
PMID: 6313906
-
Production and physiological actions of anandamide in the vasculature of the rat kidney.
J Clin Invest. 1997 Sep 15;100(6):1538-46
PMID: 9294122
-
Modulation of the cardiac autonomic transmission of pithed rats by presynaptic opioid OP4 and cannabinoid CB1 receptors.
Naunyn Schmiedebergs Arch Pharmacol. 2001 Sep;364(3):233-41
PMID: 11521166
-
Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart.
J Pharmacol Exp Ther. 2001 May;297(2):819-26
PMID: 11303075
-
Studies on the hypotensive activity of (-)-delta9-trans-tetrahydrocannabinol in anesthetized dogs.
Res Commun Chem Pathol Pharmacol. 1973 Sep;6(2):527-40
PMID: 4750101
-
Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat.
Naunyn Schmiedebergs Arch Pharmacol. 1997 Aug;356(2):197-202
PMID: 9272725
-
Mechanism of the hypotensive action of anandamide in anesthetized rats.
Hypertension. 1996 Oct;28(4):682-6
PMID: 8843898
-
Certain observations on interrelationships between respiratory and cardiovascular effects of (-)- 9 -trans-tetrahydrocannabinol.
Res Commun Chem Pathol Pharmacol. 1972 May;3(3):483-92
PMID: 5034510
-
Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves.
Br J Pharmacol. 1996 Aug;118(8):2023-8
PMID: 8864538
-
Intravenous delta9-Tetrahydrocannabinol: Effects of ventilatory control and cardiovascular dynamics.
Anesthesiology. 1975 Jun;42(6):666-73
PMID: 1130738
-
The cardiovascular and autonomic effects of repeated administration of delta-9-tetrahydrocannabinol to rhesus monkeys.
J Pharmacol Exp Ther. 1981 Feb;216(2):247-53
PMID: 6257883
-
delta9-Tetrahydrocannabinol and dimethylheptylpyran induced tachycardia in the conscious rat.
Life Sci. 1977 Nov 1;21(9):1329-36
PMID: 927033
-
Role of the central autonomic nervous system in the hypotension and bradycardia induced by (-)-delta 9-trans-tetrahydrocannabinol.
J Pharm Pharmacol. 1974 Mar;26(3):186-92
PMID: 4151077
-
Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections.
Brain Res. 1999 Mar 20;822(1-2):237-42
PMID: 10082902
-
Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex.
Br J Pharmacol. 2001 Sep;134(2):295-304
PMID: 11564647
-
Tonic glutamate-mediated control of rostral ventrolateral medulla and sympathetic vasomotor tone.
Am J Physiol. 1997 Aug;273(2 Pt 2):R487-94
PMID: 9277530
-
Delta9-tetrahydrocannabinol: depression of ventilatory regulation; other respiratory and cardiovascular effects.
Life Sci. 1976 Jul 1;19(1):99-104
PMID: 940439
-
Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms.
Clin Pharmacol Ther. 1979 Apr;25(4):440-6
PMID: 428189
-
Studies on the bradycardia induced by (-)- -trans-tetrahydrocannabinol in anesthetized dogs.
Eur J Pharmacol. 1973 Jun;22(3):263-9
PMID: 4354577
-
Functional organization of central pathways regulating the cardiovascular system.
Physiol Rev. 1994 Apr;74(2):323-64
PMID: 8171117
-
Effects of diethyl ether, halothane, ketamine and urethane on sympathetic activity in the rat.
Eur J Pharmacol. 1987 Jan 28;134(1):15-24
PMID: 3556398
-
Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide.
Eur J Pharmacol. 1995 May 24;278(3):279-83
PMID: 7589169
-
Cardiovascular actions of cannabinoids and their generation during shock.
J Mol Med (Berl). 1998 Nov-Dec;76(12):824-36
PMID: 9846953
-
Cardiovascular effects of (-)-11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl in rats.
J Cardiovasc Pharmacol. 1996 Aug;28(2):332-6
PMID: 8856492
-
Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats.
Hypertension. 1997 May;29(5):1204-10
PMID: 9149688
-
Neuronal responses to cannabinoid receptor ligands in the solitary tract nucleus.
Eur J Pharmacol. 1998 Oct 16;359(1):49-54
PMID: 9831292
-
Cannabinoids cause central sympathoexcitation and bradycardia in rabbits.
J Pharmacol Exp Ther. 2000 Aug;294(2):707-13
PMID: 10900251
-
Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A.
J Pharmacol Exp Ther. 1998 Aug;286(2):697-703
PMID: 9694923